- £224.89bn
- £242.74bn
- $58.74bn
- 93
- 13
- 97
- 81
RCS - Redx Pharma Limited - RXC008 Receives US FDA Fast Track Designation
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca prices a $2bn bond offering
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - AstraZeneca PLC - Directorate change
AnnouncementREG - AstraZeneca PLC - Fixed-duration Calquence combo approved in US
AnnouncementREG - AstraZeneca PLC - Final Results
AnnouncementREG - AstraZeneca PLC - Update on Saphnelo subcutaneous administration
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Imfinzi recommended in EU for early gastric cancer
AnnouncementREG - AstraZeneca PLC - AstraZeneca begins trading on NYSE
AnnouncementREG - AstraZeneca PLC - AstraZeneca agrees obesity and T2D deal with CSPC
AnnouncementREG - AstraZeneca PLC - AstraZeneca invests $15bn in China through 2030
AnnouncementREG - AstraZeneca PLC - AstraZeneca to complete direct listing on NYSE
AnnouncementREG - AstraZeneca PLC - AZN new Head of Investor Relations Joris Silon
Announcement